Place of Origin : Hong Kong,Hong Kong
Post Date : 24-06-2013
Expiry Date : 24-07-2020

Anastrozole (Arimidex)

MF: C17H19N5
MW: 293.37
CAS: 120511-73-1
Assay: 99%
Appearance: White Crystalline Powder
Density: 1.13g/cm³
Melting Point: 155.13℃
Flash Point:169℃
Package:foil Bag

General Introduction:Anastrozole Is A Drug Used To Treat Breast Cancer After Surgery And For Metastases In Post-menopausal Women. Anastrozole Is An Aromatase Inhibitor, Which Means That It Interrupts A Critical Step In The Body's Synthesis Of Estrogen. Some Breast Cancer Cells Require Estrogen To Grow, And Eliminating Estrogen Suppresses Their Growth. Annual Sales Approx $2.2bn. The First Patent Expired In June 2010. Although This Patent Was Originally Set To Expire In December 2009, The Manufacturer Was Given An Extension For Performing Much Needed Pediatric Studies.